EMFAT
ALDR
Emerald Mutual Fund Advisers Trust’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2018
Q3 | – | Sell |
-1,183,835
| Closed | -$18.7M | – | 265 |
|
2018
Q2 | $18.7M | Sell |
1,183,835
-162,214
| -12% | -$2.56M | 0.68% | 47 |
|
2018
Q1 | $17.1M | Sell |
1,346,049
-100,816
| -7% | -$1.28M | 0.67% | 49 |
|
2017
Q4 | $16.6M | Buy |
1,446,865
+176,310
| +14% | +$2.02M | 0.66% | 52 |
|
2017
Q3 | $15.6M | Buy |
1,270,555
+327,846
| +35% | +$4.02M | 0.65% | 53 |
|
2017
Q2 | $10.8M | Buy |
942,709
+524,746
| +126% | +$6.01M | 0.47% | 75 |
|
2017
Q1 | $8.69M | Hold |
417,963
| – | – | 0.4% | 92 |
|
2016
Q4 | $8.69M | Buy |
417,963
+33,826
| +9% | +$704K | 0.41% | 86 |
|
2016
Q3 | $12.6M | Buy |
384,137
+144,248
| +60% | +$4.73M | 0.64% | 62 |
|
2016
Q2 | $5.99M | Buy |
+239,889
| New | +$5.99M | 0.34% | 108 |
|